BioNTech Founder Uğur Şahin: “The Virus Continues To Mutate at a High Speed”
Interview with BioNTech Founder Uğur Şahin“The Virus Continues to Mutate at a High Speed” We were fortunate that Omicron turned out to be as mild as it has been, says […]
BioNTech Founder Şahin on the Omicron Variant”It Will Make Scientific Sense To Offer Booster after Three Months”
International BioNTech Founder Şahin on the Omicron Variant“It Will Make Scientific Sense To Offer Booster after Three Months” The latest mutations of the coronavirus call for a new vaccination strategy. […]
BioNTech Founders on Vaccine for Children”Things Are Looking Good and Going According to Plan”
In an interview, BioNTech founders Uğur Şahin and Özlem Türeci explain why booster shots are needed to combat the Delta variant of the coronavirus, and they say that a vaccine […]
Turkish German vaccine pioneers receive Germany’s highest award
Epigraph: Every human life is precious and sacred. One who saves a life it is as if he or she has saved the whole of humanity. (Al Quran 5:32/33) BY […]
BioNTech’s Turkish-German founders to receive Order of Merit
BY GERMAN PRESS AGENCY – DPA FRANKFURT HEALTH FEB 26, 2021 Özlem Türeci (L), chief medical officer of BioNTech, and Uğur Şahin, its CEO and co-founder, walk through one of […]
“To See People Finally Benefitting from Our Work Is Really Moving”
BioNTech Founders Türeci and Şahin on the Battle against COVID-19 In a DER SPIEGEL interview, BioNTech founders Özlem Türeci and Uğur Şahin discuss the development of the world’s first COVID-19 […]
A triumph of German innovation and immigration
Nov 30,2020 – JORDAN TIMES – Hans-Werner Sinn MUNICH — The world took note when the German start-up BioNTech announced its breakthrough in the development of a new type of vaccine to combat COVID-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95 per […]
Coronavirus: Turkish Germans raise new Covid vaccine hopes
Prof Ugur Sahin (L) and Dr Özlem Türeci A Turkish-German husband-and-wife team have emerged as frontrunners in the race to market a vaccine against coronavirus, which would be an extraordinary […]